1. Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer
    Nirmish Singla et al, 2019, Expert Opinion on Investigational Drugs CrossRef
  2. Natural Product Gossypol and its Derivatives in Precision Cancer Medicine
    Yun Zeng et al, 2019, Current Medicinal Chemistry CrossRef
  3. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
    Hao Liu et al, 2022, International Journal of Nanomedicine CrossRef
  4. A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment
    Dana Hellmold et al, 2023, Biomedical Materials CrossRef
  5. Macroscopic Silicone Microchannel Matrix for Tailored Drug Release and Localized Glioblastoma Therapy
    Florian Rasch et al, 2020, ACS Biomaterials Science & Engineering CrossRef

  6. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy


    Dorota K Flak et al, 2020, International Journal of Nanomedicine CrossRef
  7. Considering the Conception of Nanotechnology Integrated on Herbal Formulation for the Management of Cancer
    Smriti Ojha et al, 2023, Letters in Drug Design & Discovery CrossRef